

| Catalog No. | DB949018 |
|---|---|
| Description |
_x005F_x000d_
_x005F_x000d_
_x005F_x000d_
_x005F_x000d_
_x005F_x000d_
_x005F_x000d_
Bimagrumab ELISA Kit (DB949018) — Quantitative sandwich ELISA for Bimagrumab. Sample: Plasma, Serum. Range: 125 - 4, 000 ng/mL. Sensitivity: 97.28 ng/mL. _x005F_x000d_
_x005F_x000d_
_x005F_x000d_
_x005F_x000d_ Highlights _x005F_x000d_
_x005F_x000d_
|
| Sample type | Serum, plasma, and other biological fluid samples |
| Sensitivity | 3.73 ng/mL |
| Range | 31.25 – 1,000 ng/mL |
| Species reactivity | Human |
| Target | ACVR2A,ACVR2B |
| Accession | P27037,Q13705 |
| Applications | ELISA |
| Detection method | Colorimetric |
| Assay type | Competitive |
| Recovery | 80-120% |
| Shipping | 2-8 ℃ |
| Stability and Storage | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20 ℃, the rest reagents should be store at 4℃. |
| Specifications | Bimagrumab _x005F_x000d_ |
| Alternate Names | BYM338, 1356922-05-8 |
| Background | Bimagrumab is a monoclonal anti-ActRIIA/IIB antibody that targets ActRIIA and ActRIIB simultaneously. Native ActRIIA and ActRIIB are both mediators of signaling from several TGFβ superfamily members such as activins, myostatin, and GDF11. Hence, pan-blockade by Bimagrumab achieves greater effect than a monoclonal antibody against either receptor alone, i.e. monotherapy with anti-ActRIIA antibody or anti-ActRIIB antibody. Bimagrumab has been explored as a therapy for sporadic inclusion body myositis, primary sarcopenia, and muscle wasting associated with chronic obstructive pulmonary disease. _x005F_x000d_ |
| Note | For Research Use Only. |

Standard Curve of Bimagrumab ELISA Kit
Contact us for custom quotes, bulk requests and any other issues.
Mail: [email protected]


Quick access
Contact Us
+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский